Board of Directors:
Ian N. Askill, Ph.D. - Founder

Dr. Askill has been developing biomaterials and medical devices for over 40 years. His innovations and leadership have been responsible for the development and commercialization of medical devices generating millions of dollars for client companies. Dr. Askill has a proven track record of innovation across the medical spectrum. He is the author of 25 issued US patents, covering a range of technologies including wound care, infection control, esophageal testing, and device sterilization.

During his career, Dr. Askill has developed a reputation for providing leadership in medical device development.  He has been responsible for evaluating emerging technologies and guiding new device development for many employers and clients, including Fortune 500 companies. Dr. Askill has held officer-level positions for several start-up companies, culminating in his founding of Aspire Biotech, Inc.

Dr. Askill has been active in the local science/business community, including the Science Advisory Board of the College of Letters, Arts, and Sciences for the University of Colorado at Colorado Springs; the Advisory Board of the El Pomar Institute for Innovation and Commercialization (EPIIC); the Citizens Advisory Group of the Electric Integrated Resource Plan for the local utility; Board of the South Eastern Colorado Renewable Energy Society. Dr. Askill is a strong advocate for educational advancements in science, technology, engineering, and math (STEM) and enjoys mentoring young entrepreneurs.

Dr. Colin Askill, FRCR - Founder

Dr. Askill graduated from the University of Liverpool (UK) in 1973, receiving an MB. ChB. He trained in Oncology at Christie Hospital, Manchester, UK. Dr. Askill gained DMRT (London) in 1978 and FRCR (Radiotherapy), (London) in 1980. Since 1981, Dr. Askill has worked as a Consultant Clinical Oncologist at Singleton Hospital, Swansea, Wales, UK. Dr. Askill specializes in Cancers of the Gastrointestinal tract and Lymphomas, but previously served on the Medical Research Council Testicular Tumour Working Party. He is ARSAC certified for therapeutic and diagnostic use of various radioactive materials, and GCP certified for research.

Allan S. Roth, MBA, CPA, CFP

Allan Roth is the author of the book "How a Second Grader Beats Wall Street" (Wiley, 2009) and father of the book's hero, Kevin. Allan also writes a personal finance articles for various publications, including AARP, The Wall Street Journal and Financial Planning Magazine. He is frequently quoted by the press including The Wall Street Journal and Money Magazine. He is hated by overpaid fund managers and investment advisors. Mr. Roth is the founder of Wealth Logic LLC in Colorado Springs, Colorado. Wealth Logic is an hourly-based financial planning and investment advisory firm that advises clients with portfolios ranging upwards to several hundred million dollars. Prior to founding Wealth Logic, Mr. Roth was a financial officer at two multi-billion dollar corporations. Mr. Roth has taught investing at Colorado College, the University of Colorado, and University of Denver and continues to teach investing and behavioral finance to advisors, CPAs and attorneys.